Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation

Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients With Cancer

(2013) Saroj Vadhan-Raj   ANNALS OF INTERNAL MEDICINE

A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma

(2010) G. Kobbe et al.   ANNALS OF ONCOLOGY

Effect of recombinant human keratinocyte growth factor (Δ23rHuKGF, Palifermin) on inflammatory and immune changes in mouse tongue during fractionated irradiation

(2010) Jana Jaal et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial

(2010) Anncarin Svanberg et al.   JOURNAL OF CLINICAL NURSING

Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro

(2010) Andrea Hille et al.   RADIATION AND ENVIRONMENTAL BIOPHYSICS

Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis

(2010) Zhi Ong et al.   Radiation Oncology

Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma

(2009) T Schroeder et al.   BONE MARROW TRANSPLANTATION

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

(2009) Stephen T. Sonis   ORAL ONCOLOGY

Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis

(2008) E. Schmidt et al.   ANNALS OF ONCOLOGY

Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)

(2008) John E. Levine et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients

(2008) S Langner et al.   BONE MARROW TRANSPLANTATION

Palifermin dose should be adjusted to different therapy regimens

(2008) M P M Verhagen et al.   BONE MARROW TRANSPLANTATION

Palifermin Reduces Severe Oral Mucositis in Subjects with Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy

(2008) Q. Le et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group

(2008) Nicole Blijlevens et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma

(2008) David M. Brizel et al.   JOURNAL OF CLINICAL ONCOLOGY